Literature DB >> 15834210

Resection of liver metastases from an alpha-fetoprotein-producing gastric cancer.

Tomohiro Kanda1, Hiroshi Yoshida, Yasuhiro Mamada, Nobuhiko Taniai, Youichi Kawano, Yoshiaki Mizuguchi, Tetsuya Shimizu, Tsubasa Takahashi, Junji Ueda, Shunji Kato, Koho Akimaru, Takashi Tajiri, Yuh Fukuda.   

Abstract

We describe successful resection of rapidly enlarging liver metastases from an alpha-fetoprotein-producing gastric cancer, as these usually carry a dismal prognosis. A 68-year-old woman underwent distal gastrectomy for an alpha-fetoprotein-producing gastric cancer without liver metastasis. The tumor was a moderately differentiated tubular adenocarcinoma with invasion of the muscularis propria. Venous and lymphatic invasion were noted, as was metastasis to lymph nodes along the greater curvature. Serum alpha-fetoprotein was 331 ng/mL before gastrectomy, decreasing to 18.6 ng/mL by postoperative day 28. At 2 months after operation, computed tomography detected no metastasis, but at 4 months alpha-fetoprotein increased to 2,190 ng/mL, and at 5 months liver tumors were detected by ultrasonography and computed tomography. Serum alpha-fetoprotein increased to 5,673 ng/mL, and serum PIVKA2 concentration was 18 mAU/ml just before operation. Extended left hepatectomy was performed. The resected specimen of segment 4 contained two well-defined tumors, measuring 5 x 4 cm and 2 x 2 cm, while that of segment 5 contained a similar-appearing tumor measuring 2 x 2 cm. The resected tumors had the same histologic appearance as the previously removed gastric cancer. The tumor cells were immunohistochemically reactive for alpha-fetoprotein. The postoperative course was uneventful, and the patient was discharged on postoperative day 15. Serum alpha-fetoprotein decreased to 20 ng/mL by postoperative day 15, and to 5 ng/mL by 2 months after operation. For 5 months since operation, no recurrence has become evident, and serum alpha-fetoprotein has remained within the normal range.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15834210     DOI: 10.1272/jnms.72.66

Source DB:  PubMed          Journal:  J Nippon Med Sch        ISSN: 1345-4676            Impact factor:   0.920


  3 in total

1.  A case report of retroperitoneal extrahepatic hepatocellular carcinoma presented with elevated level of Alpha fetoprotein.

Authors:  S Yuce; Oz Sahin; R Bedir; T Ayaz; T Durakoglugil
Journal:  Hippokratia       Date:  2014-01       Impact factor: 0.471

Review 2.  Persistent increase in alpha-fetoprotein level in a patient without underlying liver disease who underwent curative resection of hepatocellular carcinoma. A case report and review of the literature.

Authors:  Isidoro Di Carlo; Maurizio Mannino; Adriana Toro; Annalisa Ardiri; Antonio Galia; Giovanni Cappello; Gaetano Bertino
Journal:  World J Surg Oncol       Date:  2012-05-06       Impact factor: 2.754

3.  Prognostic significance of α-fetoprotein in gastric adenocarcinoma.

Authors:  Sezgin Vatansever; Merve Kılınç Özer; Elvan Işık Erdoğan
Journal:  Prz Gastroenterol       Date:  2022-03-18
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.